Influence of a negative sestamibi scan on the decision for parathyroid operation by the endocrinologist and surgeon.

Background: It has been observed that negative sestamibi scans may impact practice patterns in patients with primary hyperparathyroidism. However, there are no published data on the issue. The objective was to elucidate the influence of negative sestamibi scans on referrals by endocrinologists for parathyroidectomy and surgeon decision-making.

Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System.

There are many different methods of treating obesity, ranging from various medical options to several surgical therapies. This paper briefly summarizes current surgical options for weight loss with a focus on one of the newest US Food and Drug Administration-approved devices for surgical weight loss therapy, the Maestro Rechargeable System. Also known as the vagal blocking for obesity control implantable device, this tool blocks vagal nerve activity to induce weight loss.

Gallstone pancreatitis without cholecystectomy.

Importance: Current guidelines recommend that patients with an initial episode of gallstone pancreatitis receive cholecystectomy. However, for various reasons, many patients do not.

Objective: To determine the risk of developing recurrent gallstone pancreatitis in patients who never receive a cholecystectomy.

Diverticulitis in transplant patients and patients on chronic corticosteroid therapy: a systematic review.

Background: The clinical course of diverticular disease in immunosuppressed patients is widely believed to be more severe than in the general population. In this study we systematically reviewed the literature regarding the epidemiology and clinical course of diverticulitis in immunosuppressed patients. Our goal was to develop recommendations regarding the care of this group of patients.